Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device

Background/Purpose: Anticoagulant therapy is suggested within 45 days after Watchman device implantation for stroke prevention in patients with atrial fibrillation (AF). A previous study demonstrated that non-vitamin K antagonist oral anticoagulants (NOACs) were a feasible peri- and postprocedural a...

Full description

Bibliographic Details

Published in:	Journal of the Formosan Medical Association
Main Authors:	Guohua Fu, Binhao Wang, Bin He, Yibo Yu, Zhao Wang, Mingjun Feng, Jing Liu, Xianfeng Du, Weidong Zhuo, Huimin Chu
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Subjects:	Left atrial appendage closure Watchman device Non-vitamin K antagonist Oral anticoagulants Low-dose Thromboembolic event
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664621004873